Till Capital Announces Results of Annual General Meeting
Aug 24, 2016 21:00 pm UTC| Business
HAMILTON, Bermuda, Aug. 24, 2016 -- Till Capital Ltd. (Nasdaq:TIL) (TSX.V:TIL) (“Till”), reports the results of its Annual General Meeting (“AGM”) held on August 23, 2016 in Hayden, Idaho. All of the proposed...
Beasley Broadcast Group Declares Quarterly Cash Dividend of $0.045 Per Share
Aug 24, 2016 20:34 pm UTC| Business
NAPLES, Fla., Aug. 24, 2016 -- Beasley Broadcast Group, Inc. (Nasdaq:BBGI) (“the Company”), a large- and mid-size market radio broadcaster, announced today that its Board of Directors declared a quarterly cash dividend...
Aug 24, 2016 20:30 pm UTC| Business
SUNNYVALE, Calif., Aug. 24, 2016 -- Proofpoint, Inc., (NASDAQ:PFPT), a leading next-generation cybersecurity company, has acquired Return Path’s Email Fraud Protection (EFP) business unit. Return Path’s EFP business,...
State Bank Financial Corporation Declares Quarterly Cash Dividend
Aug 24, 2016 20:30 pm UTC| Business
ATLANTA, Aug. 24, 2016 -- The Board of Directors of State Bank Financial Corporation (NASDAQ:STBZ) today declared a quarterly dividend of $.14 per common share. The dividend will be paid on September 13, 2016 to the...
Aug 24, 2016 20:20 pm UTC| Business
HOLLYWOOD, Fla. and MIAMI, Aug. 24, 2016 -- HEICO CORPORATION (NYSE:HEI.A) (NYSE:HEI) today reported that net income increased 22% to a record $42.0 million, or 62 cents per diluted share, in the third quarter of fiscal...
Southwest Georgia Financial Corporation Increases Quarterly Cash Dividend 10%
Aug 24, 2016 20:18 pm UTC| Business
MOULTRIE, Ga., Aug. 24, 2016 -- Southwest Georgia Financial Corporation (NYSE MKT:SGB), the parent company of Southwest Georgia Bank, announced that its Board of Directors has declared a quarterly cash dividend of $0.11...
BeiGene Appoints Amy Peterson, M.D. as Chief Medical Officer, Immuno-oncology
Aug 24, 2016 20:15 pm UTC| Business
WALTHAM, Mass., Aug. 24, 2016 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today...